Herceptin letter
Herceptin letter There was a good letter about Herceptin in the Independent today, in which the writer pointed out that the cost of Herceptin (which no doubt includes a clawback of the R&D costs) seems very high when you consider that the potential user base for the drug is quite large. It’s not as though it can only be used for a handful of patients worldwide…